M815-2165 Screening compound: N-[(4-chlorophenyl)methyl]-2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}acetamide

M815-2165 Screening compound: N-[(4-chlorophenyl)methyl]-2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}acetamide
M815-2165 Screening compound: N-[(4-chlorophenyl)methyl]-2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M815-2165
N-[(4-chlorophenyl)methyl]-2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M815-2165

Molecular Formula

C22H22ClFN4O2 (C22 H22 ClFN4 O2)

Compound Name

N-[(4-chlorophenyl)methyl]-2-{4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}acetamide

IUPAC name

N-[(4-chlorophenyl)methyl]-2-{4-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]piperidin-1-yl}acetamide

SMILES

O=C(CN(CC1)CCC1c1nc(-c(cc2)ccc2F)no1)NCc(cc1)ccc1Cl

InChI

InChI=1S/C22H22ClFN4O2/c23-18-5-1-15(2-6-18)13-25-20(29)14-28-11-9-17(10-12-28)22-26-21(27-30-22)16-3-7-19(24)8-4-16/h1-8,17H,9-14H2,(H,25,29)

InChI Key

BUIWVTHDTIERNS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27555092

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.89

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.983

Distribution Coefficient, logD

4.914

Water Solubility, LogSw

-5.27

Polar Surface Area

59.848

Acid Dissociation Constant (pKa)

12.65

Base Dissociation Constant (pKb)

6.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

M815-2165 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with M815-2165 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M815-2165?
Check Price and Availability of M815-2165, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M815-2165 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M815-2165
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M815-2165
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M815-2165 available by request